Targeted drug delivery to macrophages

scientific article published on 06 January 2013

Targeted drug delivery to macrophages is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1517/17425247.2013.751370
P8608Fatcat IDrelease_frxwhe5jjrf7hlupxfmeo47nwe
P698PubMed publication ID23289618
P5875ResearchGate publication ID234068265

P2093author name stringVijay Mishra
Narendra K Jain
Neelesh Kumar Mehra
P2860cites workDirect and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of ironQ23923113
Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patientsQ24312144
Cell size of alveolar macrophages: an interspecies comparisonQ24545527
Exploring the full spectrum of macrophage activationQ24653754
Helical microtubules of graphitic carbonQ25939001
HIV-1 gp120 chemokine receptor-mediated signaling in human macrophagesQ28186856
The role of dendritic cell C-type lectin receptors in HIV pathogenesisQ28205428
Uptake of Pneumocystis carinii mediated by the macrophage mannose receptorQ28301754
Protective and pathogenic functions of macrophage subsetsQ29620351
The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes.Q30985134
Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitroQ33337567
Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma modelQ33404233
Superparamagnetic iron oxide nanoparticles coated with mannan for macrophage targetingQ33406466
Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemiaQ33852399
Folic acid-functionalized human serum albumin nanocapsules for targeted drug delivery to chronically activated macrophages.Q34177890
Self-Assembled Block Copolymer Aggregates: From Micelles to Vesicles and their Biological ApplicationsQ34195552
Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cellsQ34269349
Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.Q34537587
Dectin-1 and its role in the recognition of beta-glucans by macrophagesQ35617619
Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubesQ35838239
Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone.Q36142511
Nanotechnology-based drug delivery systemsQ36419770
Role of nanotechnology in targeted drug delivery and imaging: a concise reviewQ36733049
Review: Immune cells and mediators of inflammatory arthritisQ37118782
Challenges in the use of carbon nanotubes for biomedical applicationsQ37186751
Role of MIF in inflammation and tumorigenesisQ37268688
Polymersome delivery of siRNA and antisense oligonucleotides.Q37338790
Stimuli-responsive polymersomes for programmed drug deliveryQ37362426
Surface-engineered dendrimers: a solution for toxicity issuesQ37372870
Dendrimer toxicity: Let's meet the challenge.Q37740264
Strategies in the design of nanoparticles for therapeutic applicationsQ37771241
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responsesQ37785952
A review of glycosylated carriers for drug delivery.Q37991459
Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease.Q38016165
Targeted polymersome delivery of siRNA induces cell death of breast cancer cells dependent upon Orai3 protein expressionQ39309089
Multi-walled carbon nanotubes induce apoptosis via mitochondrial pathway and scavenger receptor.Q39337288
Comparison of cytotoxic and inflammatory responses of pristine and functionalized multi-walled carbon nanotubes in RAW 264.7 mouse macrophagesQ39358703
Cytotoxicity of functionalized carbon nanotubes in J774A macrophagesQ39451711
Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory responseQ39454496
Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug deliveryQ39502231
Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasisQ39547523
In vivo targeting of alveolar macrophages via RAFT-based glycopolymersQ39590398
Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosisQ39605166
Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A.Q39658224
Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophagesQ39768612
In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasisQ39819371
Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.Q39954346
Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosisQ39974307
Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infectionsQ40019265
Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modificationQ40182605
Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicinQ40534061
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammationQ40832683
Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytesQ41994305
Identification of macrophage migration inhibitory factor (MIF) in human skin and its immmunohistochemical localization.Q42515901
Augmented inhibitory effect of superoxide dismutase on superoxide anion release from macrophages by chemical modification with polysaccharide and attenuation effects on radiation-induced inflammatory cytokine expression in vitroQ42797716
Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transductionQ42950741
Mannosylated nanoparticulate carriers of rifabutin for alveolar targetingQ43235591
Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticlesQ43258446
Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma modelQ44005705
Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophagesQ44368025
Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblastsQ44634051
Carbohydrate-conjugated multiwalled carbon nanotubes: development and characterizationQ46063840
Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cellsQ46374200
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in ratsQ46883258
Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserineQ46927876
Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.Q51089608
Precision intracellular delivery based on optofluidic polymersome rupture.Q54697556
HIV-1 and the macrophageQ55967625
Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimersQ57187420
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectdrug deliveryQ1392806
P304page(s)353-367
P577publication date2013-01-06
P1433published inExpert Opinion on Drug DeliveryQ5421203
P1476titleTargeted drug delivery to macrophages
P478volume10

Reverse relations

cites work (P2860)
Q64074601Acoustic tweezing cytometry for mechanical phenotyping of macrophages and mechanopharmaceutical cytotripsy
Q28082463Active targeted drug delivery for microbes using nano-carriers
Q40735074Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles.
Q35204972Bacteriophages and medical oncology: targeted gene therapy of cancer
Q53076778CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.
Q55261866Chemical Reactive Anchoring Lipids with Different Performance for Cell Surface Re-engineering Application.
Q38967744Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles
Q28388944Defect density in multiwalled carbon nanotubes influences ovalbumin adsorption and promotes macrophage activation and CD4(+) T-cell proliferation
Q38555022Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential
Q38292341Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications
Q38729357Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis
Q39131075Development, characterization and cancer targeting potential of surface engineered carbon nanotubes
Q38537751Drug Trafficking into Macrophages via the Endocytotic Receptor CD163.
Q28085174Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury
Q39094882Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage
Q39181834Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells
Q58830266Glucan particles loaded with a NIRF agent for imaging monocytes/macrophages recruitment in a mouse model of rheumatoid arthritis
Q26768497Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases
Q96954739Liposomal Delivery of Mycophenolic Acid With Quercetin for Improved Breast Cancer Therapy in SD Rats
Q38126942Liposomal formulations for inhalation
Q38211726Macrophages associated with tumors as potential targets and therapeutic intermediates
Q41094809Maternal dendrimer-based therapy for inflammation-induced preterm birth and perinatal brain injury
Q38685760Modulators of microglia: a patent review
Q38543087Multifunctional hybrid-carbon nanotubes: new horizon in drug delivery and targeting
Q38961842Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy
Q39069052Nanomedicines for dysfunctional macrophage-associated diseases
Q38213218Nanovector-mediated drug delivery for spinal cord injury treatment.
Q30845058Novel poly(ethylene oxide)-b-poly(propylene oxide) copolymer-glucose conjugate by the microwave-assisted ring opening of a sugar lactone
Q57460363Regenerative Strategies for the Central Nervous System
Q37541839Scavenger Receptor-Mediated Targeted Treatment of Collagen-Induced Arthritis by Dextran Sulfate-Methotrexate Prodrug
Q37502278Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells.
Q51227992Surviving nebulization-induced stress: dexamethasone in pH-sensitive archaeosomes.
Q36505647The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy

Search more.